SMTI: Ascending Triangle detected on 17 Sep 2026

SMTI is forming an ascending triangle pattern with a structure score of 13/15, indicating a well-defined upper resistance at $35.14 and rising lower support near $35.02. Current price of $35.10 sits near the apex, up 3.24% in one month and 54.69% over three months, positioning the stock 1.2% from its 52-week high. The breakout score of 7/13 and volume score of 7/12 reveal moderate quality concerns: current volume of 116,201 shares is only 40% of the 20-day average (289,762), and MACD histogram shows negative divergence at -0.2151, suggesting weakening momentum despite price strength.

Sanara is expected to be acquired by MIMEDX, subject to customary closing conditions. This transformational development was announced in August 2026 and fundamentally alters the stock's narrative. Q1 2026 reported net revenue of $27.8 million, up 19% year-over-year, with net income from continuing operations of $0.4 million ($0.04 per diluted share). Q2 2026 revenue rose 9% to $28.1 million with 93% gross margin and $1.8 million operating income. Lake Street reaffirmed a Hold rating on August 26, 2026, while Freedom Broker downgraded to Hold from Buy on August 3, 2026. The acquisition news likely triggered the recent 55% rally, but analyst downgrades suggest market caution about valuation ahead of deal closure.

A successful breakout above $35.14 resistance would target $36.51 (conservative target), representing a 4% measured move higher. Volume confirmation is critical—breakout volume should exceed 289,762 shares (20-day average) to validate the move. The pattern invalidates below key support at $35.02, a narrow 0.34% buffer indicating high precision. With a 54.11% win probability, the pattern offers only marginal edge. The ascending triangle typically requires a sustained close above resistance with volume expansion; the current low relative volume (0.4) and weak breakout/volume scores suggest breakout confirmation would need significant buying pressure.

SMTI was downgraded to Hold from Buy by Freedom Broker on August 3 and reaffirmed Hold by Lake Street on August 26, 2026. The RSI of 76.79 is overbought (>70), signaling potential pullback risk into the pattern. Volume is critically weak—only 40% of average despite a 54% three-month rally, suggesting retail exhaustion or institutional caution ahead of the MIMEDX acquisition closing. The MACD histogram turning negative despite price strength flags momentum deterioration. Delta of -0.14 and price having rallied 1.2% above the 52-week high creates exhaustion risk. Acquisition uncertainty remains—any deal delay, financing issues, or regulatory obstacles could collapse this triangle structure rapidly. The narrow support-resistance bands ($35.02 to $35.14) offer minimal risk cushion.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.